Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes-Reference-Cited by-同舟云学术

Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes

Published:2014-05 Issue:7 Volume:50 Page:1361-1369
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Yang Ching-Yao,Lin Mong-Wei,Chang Yih-Leong,Wu Chen-Tu,Yang Pan-Chyr

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

3. Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

4. Targeted therapies for advanced non-small-cell lung cancer: current status and future implications;Custodio;Cancer Treat Rev,2012

5. Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease;Ohashi;J Clin Oncol,2013

Cited by 263 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC;Journal for ImmunoTherapy of Cancer;2024-04

2. Revisiting the impact of clinicopathologic characteristics in PD-L1 profile in a large cohort of non-small cell lung cancer;Translational Lung Cancer Research;2024-03

3. Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data;Frontiers in Oncology;2024-01-31

4. PD-L1 expression and its significance in advanced NSCLC: real-world experience from a tertiary care center;Journal of the Egyptian National Cancer Institute;2024-01-29

5. Clinicopathological characteristics correlated with programmed cell death-ligand 1 expression in advanced lung adenocarcinoma;Journal of Thoracic Disease;2023-10